Published in J Immunol on September 01, 1993
Inflammatory responses induced by the filarial nematode Brugia malayi are mediated by lipopolysaccharide-like activity from endosymbiotic Wolbachia bacteria. J Exp Med (2000) 1.91
Opposing effects of interferon-gamma on iNOS and interleukin-10 expression in lipopolysaccharide- and mycobacterial lipoarabinomannan-stimulated macrophages. Immunology (1995) 1.01
CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages. Infect Immun (1995) 0.95
Phosphoglucomutase of Yersinia pestis is required for autoaggregation and polymyxin B resistance. Infect Immun (2009) 0.86
Biological characterization of endotoxins released from antibiotic-treated Pseudomonas aeruginosa and Escherichia coli. Antimicrob Agents Chemother (1998) 0.85
Microtubule-disrupting agents inhibit nitric oxide production in murine peritoneal macrophages stimulated with lipopolysaccharide or paclitaxel (Taxol). Infect Immun (1996) 0.82
Endotoxins and disease mechanisms. Annu Rev Med (1987) 6.07
The effects of bacterial endotoxins on host mediation systems. A review. Am J Pathol (1978) 6.03
Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J (1994) 5.70
Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry (1976) 5.43
Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures. J Biol Chem (1975) 4.80
Bacterial endotoxins and host immune responses. Adv Immunol (1979) 4.50
Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS). J Immunol (1977) 4.35
Nature and linkages of the fatty acids present in the lipid-A component of Salmonella lipopolysaccharides. Eur J Biochem (1972) 4.15
Interaction of lipopolysaccharides and lipid A with complement. Eur J Biochem (1971) 4.15
Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur J Biochem (1985) 3.76
Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res (2001) 3.46
Immunologic properties of bacterial lipopolysaccharide (LPS): correlation between the mitogenic, adjuvant, and immunogenic activities. J Immunol (1975) 3.18
Biological activities of lipid A complexed with bovine-serum albumin. Eur J Biochem (1972) 3.04
Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutants of Salmonella typhimurium. FEBS Lett (1981) 2.91
Isolation of a lipid A bound polypeptide responsible for "LPS-initiated" mitogenesis of C3H/HeJ spleen cells. J Exp Med (1976) 2.88
Mothers as behavior therapists for their own children. Behav Res Ther (1965) 2.86
Relationship of the structure of bacterial lipopolysaccharides to its function in mitogenesis and adjuvanticity. Proc Natl Acad Sci U S A (1973) 2.61
IL-1 induction-capacity of defined lipopolysaccharide partial structures. J Immunol (1989) 2.41
Bactericidal activity of the alternative complement pathway generated from 11 isolated plasma proteins. J Exp Med (1979) 2.39
A lethal role for lipid A in Salmonella infections. Mol Microbiol (1998) 2.30
Stimulation of a T-independent primary anti-hapten response in vitro by TNP-lipopolysaccharide (TNP-LPS). J Immunol (1975) 2.30
Immunologic properties of bacterial lipopolysaccharide (LPS). II. The unresponsiveness of C3H/HeJ Mouse spleen cells to LPS-induced mitogenesis is dependent on the method used to extract LPS. J Exp Med (1975) 2.22
An interferon-gamma-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-gamma and lipopolysaccharide. J Biol Chem (1997) 2.17
Dissociation between mitogenicity and immunogenicity of TNP-lipopolysaccharide, a T-independent antigen. J Exp Med (1975) 2.10
Molecular mechanisms of endotoxin activity. Arch Microbiol (1995) 1.98
Mediation systems in bacterial lipopolysaccharide-induced hypotension and disseminated intravascular coagulation. I. The role of complement. J Exp Med (1975) 1.91
-308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflamm (1997) 1.91
Isolation and analysis of the lipid A backbone. Lipid A structure of lipopolysaccharides from various bacterial groups. Eur J Biochem (1976) 1.87
Specific endotoxic lipopolysaccharide-binding receptors on murine splenocytes. III. Binding specificity and characterization. J Immunol (1991) 1.86
Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. Eur J Biochem (2000) 1.85
High state of order of isolated bacterial lipopolysaccharide and its possible contribution to the permeation barrier property of the outer membrane. J Bacteriol (1985) 1.85
Lipopolysaccharide nomenclature--past, present, and future. J Bacteriol (1986) 1.80
Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins). J Exp Med (1974) 1.74
Lipid A: chemical structure and biological activity. J Infect Dis (1973) 1.73
Chemical structure of the lipopolysaccharide of Haemophilus influenzae strain I-69 Rd-/b+. Description of a novel deep-rough chemotype. Eur J Biochem (1988) 1.73
Specific endotoxic lipopolysaccharide-binding proteins on murine splenocytes. I. Detection of lipopolysaccharide-binding sites on splenocytes and splenocyte subpopulations. J Immunol (1988) 1.73
Chemical structure and biological activities of lipid A's from various bacterial families. Naturwissenschaften (1978) 1.69
The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology (1993) 1.69
The chemical structure of lipid A. Demonstration of amide-linked 3-acyloxyacyl residues in Salmonella minnesota Re lipopolysaccharide. Eur J Biochem (1982) 1.67
Activation of the alternative complement pathway: recognition of surface structures on activators by bound C3b. J Immunol (1980) 1.65
Synthesis and biochemical characterization of a photoactivatable, iodinatable, cleavable bacterial lipopolysaccharide derivative. J Biol Chem (1985) 1.64
Characterization of the epitope specificity of murine monoclonal antibodies directed against lipid A. Infect Immun (1992) 1.61
Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect Immun (1994) 1.59
Biological activities of synthetic lipid A analogs: pyrogenicity, lethal toxicity, anticomplement activity, and induction of gelation of Limulus amoebocyte lysate. Infect Immun (1984) 1.59
Inhibition of the mitogenic response to lipopolysaccharide (LPS) in mouse spleen cells by polymyxin B. J Immunol (1977) 1.57
Lipopolysaccharide-induced selective priming effects on tumor necrosis factor alpha and nitric oxide production in mouse peritoneal macrophages. J Exp Med (1993) 1.57
Bacterial endotoxins: chemical structure, biological activity and role in septicaemia. Scand J Infect Dis Suppl (1982) 1.56
Prostaglandin and thromboxane synthesis in a pure macrophage population and the inhibition, by E-type prostaglandins, of chemiluminescence. FEBS Lett (1978) 1.55
Chemical structure of the lipid A component of the lipopolysaccharide from a Proteus mirabilis Re-mutant. Eur J Biochem (1983) 1.54
Binding and activation of the first component of human complement by the lipid A region of lipopolysaccharides. J Immunol (1978) 1.53
Inhibition of lipopolysaccharide-initiated activation of serum complement by polymyxin B. Infect Immun (1976) 1.53
The pulmonary vascular sequestration of neutrophils in endotoxemia is initiated by an effect of endotoxin on the neutrophil in the rabbit. Am Rev Respir Dis (1987) 1.52
Fatal granuloma necrosis without exacerbated mycobacterial growth in tumor necrosis factor receptor p55 gene-deficient mice intravenously infected with Mycobacterium avium. Infect Immun (1999) 1.52
The immunogenicity and antigenicity of lipid A are influenced by its physicochemical state and environment. Infect Immun (1987) 1.49
Lipid A-dependent lymphocyte proliferation in "endotoxin-nonresponder" mice. Rev Infect Dis (1984) 1.49
Chemical characterization of Campylobacter jejuni lipopolysaccharides containing N-acetylneuraminic acid and 2,3-diamino-2,3-dideoxy-D-glucose. J Bacteriol (1991) 1.46
Structure-activity relationships of bacterial lipopolysaccharides (endotoxins). Current and future aspects. Zentralbl Bakteriol Mikrobiol Hyg A (1988) 1.46
Structural characterization of the lipid A component of pathogenic Neisseria meningitidis. J Bacteriol (1992) 1.46
The extent of traumatic damage determines a graded depression of the endotoxin responsiveness of peripheral blood mononuclear cells from patients with blunt injuries. Crit Care Med (1999) 1.46
Specific endotoxic lipopolysaccharide-binding proteins on murine splenocytes. II. Membrane localization and binding characteristics. J Immunol (1988) 1.43
Structural characterization of the lipid A component of Bacteroides fragilis strain NCTC 9343 lipopolysaccharide. Eur J Biochem (1989) 1.42
Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes. Infect Immun (1997) 1.40
Cutting edge: bacterial DNA and LPS act in synergy in inducing nitric oxide production in RAW 264.7 macrophages. J Immunol (1999) 1.39
Pyrogenicity and immunogenicity of lipid A complexed with bovine serum albumin or human serum albumin. Infect Immun (1973) 1.38
Chemical structure of glycosphingolipids isolated from Sphingomonas paucimobilis. FEBS Lett (1991) 1.37
The lipopolysaccharide of Legionella pneumophila serogroup 1 (strain Philadelphia 1): chemical structure and biological significance. Prog Clin Biol Res (1995) 1.37
Induction of human interleukin 1 by bacterial and synthetic lipid A. Eur J Immunol (1986) 1.36
Biological activities of chemically modified endotoxins. Eur J Biochem (1971) 1.36
Chemical characterization of Chlamydia trachomatis lipopolysaccharide. Infect Immun (1985) 1.36
Lipid A, the endotoxic center of bacterial lipopolysaccharides: relation of chemical structure to biological activity. Prog Clin Biol Res (1987) 1.35
Concepts of the chemical structure of lipid A. Rev Infect Dis (1984) 1.34
Stimulation of human T lymphocytes by LPS is MHC unrestricted, but strongly dependent on B7 interactions. J Immunol (1998) 1.34
Alpha-2----4-interlinked 3-deoxy-D-manno-octulosonic acid disaccharide. A common constituent of enterobacterial lipopolysaccharides. Eur J Biochem (1984) 1.33
Bacterial endotoxins and pathogenesis. Rev Infect Dis (1983) 1.33
Endotoxic properties of chemically synthesized lipid A part structures. Comparison of synthetic lipid A precursor and synthetic analogues with biosynthetic lipid A precursor and free lipid A. Eur J Biochem (1984) 1.33
Molecular structure of lipid A, the endotoxic center of bacterial lipopolysaccharides. Adv Carbohydr Chem Biochem (1994) 1.31
Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge. J Immunol (1993) 1.30
Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12. J Immunol (1998) 1.30
Studies on membrane synthesis in Bacillus megaterium KM. J Mol Biol (1970) 1.30
Activation of rat mast cells by low molecular weight stimuli. J Immunol (1974) 1.28
Tertiary structure of Staphylococcus aureus cell wall murein. J Bacteriol (2004) 1.27
The charge of endotoxin molecules influences their conformation and IL-6-inducing capacity. J Immunol (1998) 1.27
An in vitro line of the B cell tumor BCL1 can be activated by LPS to secrete IgM1. J Immunol (1980) 1.25
Therapeutic efficacy of a polymyxin B-dextran 70 conjugate in experimental model of endotoxemia. Antimicrob Agents Chemother (1995) 1.25
Stimulation of T-independent antibody responses by hapten-lipopolysaccharides without repeating polymeric structure. Infect Immun (1979) 1.24
Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia. Infect Immun (1998) 1.24
Lipopolysaccharides (LPS) of oral black-pigmented bacteria induce tumor necrosis factor production by LPS-refractory C3H/HeJ macrophages in a way different from that of Salmonella LPS. Infect Immun (1999) 1.24
Conversion of lipopolysaccharides to molecular aggregates with reduced subunit heterogeneity: demonstration of LPS-responsiveness in "endotoxin-unresponsive" C3H/HeJ splenocytes. J Immunol (1983) 1.24
Lipid A antiserum-mediated protection against lipopolysaccharide- and lipid A-induced fever and skin necrosis. Infect Immun (1977) 1.23
Structural characterization of the lipid A component of Pseudomonas aeruginosa wild-type and rough mutant lipopolysaccharides. Eur J Biochem (1991) 1.23
Macrophage stimulation by bacterial lipopolysaccharides. II. Evidence for differentiation signals delivered by lipid A and by a protein rich fraction of lipopolysaccharides. J Exp Med (1978) 1.22
Lipopolysaccharides: structural principles and biologic activities. Rev Infect Dis (1984) 1.22
Nature, type of linkage, quantity, and absolute configuration of (3-hydroxy) fatty acids in lipopolysaccharides from Bacteroides fragilis NCTC 9343 and related strains. J Bacteriol (1980) 1.21
Bacterial DNA and lipopolysaccharide induce synergistic production of TNF-alpha through a post-transcriptional mechanism. J Immunol (2001) 1.21
Biological activities of lipopolysaccharides and lipid A from Rhodospirillaceae. Infect Immun (1977) 1.21
Commercial preparations of lipoteichoic acid contain endotoxin that contributes to activation of mouse macrophages in vitro. Infect Immun (2001) 1.21
Biological activity of synthetic phosphonooxyethyl analogs of lipid A and lipid A partial structures. Infect Immun (1992) 1.20
Lipopolysaccharide-binding protein mediates CD14-independent intercalation of lipopolysaccharide into phospholipid membranes. FEBS Lett (1996) 1.19